Skip to main content
RAPT Therapeutics, Inc. logo

RAPT Therapeutics, Inc. — Investor Relations & Filings

Ticker · RAPT ISIN · US75382E1091 LEI · 549300MB473BIU78ES48 US Manufacturing
Filings indexed 534 across all filing types
Latest filing 2021-02-16 Major Shareholding Noti…
Country US United States of America
Listing US RAPT

About RAPT Therapeutics, Inc.

https://rapt.com/

RAPT Therapeutics, Inc. is a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing, and commercializing novel therapies for patients with inflammatory and immunologic diseases. The company's scientific approach involves developing therapeutics that intelligently target key drivers of the immune system. Its pipeline includes ozureprubart (RPT904), a long-acting anti-IgE antibody being evaluated in a Phase 2b clinical trial for the treatment of food allergies.

Recent filings

Filing Released Lang Actions
SC 13G/A
Major Shareholding Notification
2021-02-16 English
PRIMARY DOCUMENT
Director's Dealing
2021-02-16 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-02-16 English
SC 13G/A
Major Shareholding Notification
2021-02-16 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated February 4, 2021, reporting a change in the company's principal accounting officer and the resignation of a Vice President, Finance and Corporate Controller. The key section is Item 5.02, which pertains to the departure and appointment of directors or certain officers. There is no financial data or report attached, and the document is relatively short (3600 characters). This fits the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2021-02-04 English
PRIMARY DOCUMENT
Director's Dealing
2021-02-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.